These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
529 related items for PubMed ID: 9402266
1. Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle. Juul A, Scheike T, Pedersen AT, Main KM, Andersson AM, Pedersen LM, Skakkebaek NE. Hum Reprod; 1997 Oct; 12(10):2123-8. PubMed ID: 9402266 [Abstract] [Full Text] [Related]
2. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men. Münzer T, Rosen CJ, Harman SM, Pabst KM, St Clair C, Sorkin JD, Blackman MR. Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864 [Abstract] [Full Text] [Related]
3. Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle. Thierry van Dessel HJ, Chandrasekher Y, Yap OW, Lee PD, Hintz RL, Faessen GH, Braat DD, Fauser BC, Giudice LC. J Clin Endocrinol Metab; 1996 Mar; 81(3):1224-31. PubMed ID: 8772603 [Abstract] [Full Text] [Related]
4. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life. Aguiar-Oliveira MH, Gill MS, de A Barretto ES, Alcântara MR, Miraki-Moud F, Menezes CA, Souza AH, Martinelli CE, Pereira FA, Salvatori R, Levine MA, Shalet SM, Camacho-Hubner C, Clayton PE. J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659 [Abstract] [Full Text] [Related]
5. Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients. Invitti C, Fatti L, Camboni MG, Porcu L, Danesi L, Delitala G, Cavagnini F. J Endocrinol Invest; 1996 Sep; 19(8):548-55. PubMed ID: 8905479 [Abstract] [Full Text] [Related]
6. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency. Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K. J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263 [Abstract] [Full Text] [Related]
7. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB. Int J Obes Relat Metab Disord; 1997 May; 21(5):355-9. PubMed ID: 9152736 [Abstract] [Full Text] [Related]
8. Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein-1 and -3 in women with regular menstrual cycles. Wang HS, Lee JD, Soong YK. Fertil Steril; 1995 Jun; 63(6):1204-9. PubMed ID: 7538473 [Abstract] [Full Text] [Related]
9. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes. Dall R, Lange KH, Kjaer M, Jørgensen JO, Christiansen JS, Orskov H, Flyvbjerg A. J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029 [Abstract] [Full Text] [Related]
10. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone. Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS. Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221 [Abstract] [Full Text] [Related]
11. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3. Juul A, Kastrup KW, Pedersen SA, Skakkebaek NE. J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596 [Abstract] [Full Text] [Related]
12. Alterations in the insulin-like growth factor system during the menstrual cycle in normal women. Helle SI, Anker GB, Meadows KA, Holly JM, Lønning PE. Maturitas; 1998 Jan 12; 28(3):259-65. PubMed ID: 9571602 [Abstract] [Full Text] [Related]
13. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure. Houang M, Cabrol S, Perin L, Ducos B, Bensman A, Le Bouc Y. Growth Horm IGF Res; 2000 Dec 12; 10(6):332-41. PubMed ID: 11161964 [Abstract] [Full Text] [Related]
19. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations. Bernardi F, Petraglia F, Seppala M, Spinetti A, Bertolini S, Ferdeghini M, Genazzani AR. Hum Reprod; 1998 Feb 12; 13(2):279-84. PubMed ID: 9557822 [Abstract] [Full Text] [Related]
20. Insulin-like growth factor system in patients with HIV infection: effect of exogenous growth hormone administration. Mynarcik DC, Frost RA, Lang CH, DeCristofaro K, McNurlan MA, Garlick PJ, Steigbigel RT, Fuhrer J, Ahnn S, Gelato MC. J Acquir Immune Defic Syndr; 1999 Sep 01; 22(1):49-55. PubMed ID: 10534146 [Abstract] [Full Text] [Related] Page: [Next] [New Search]